학술논문

Phase i study of the 177 Lu-DOTA 0 -Tyr 3 -Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung
Document Type
Article
Source
In: Journal for ImmunoTherapy of Cancer. (Journal for ImmunoTherapy of Cancer, 2 July 2020, 8(2))
Subject
Language
English
ISSN
20511426